A Convertible Preferred Stock financing of Alimera Sciences
page 1 of 1
O'Melveny & Myers LLP represented Palo Alto Investors and Sofinnova Ventures in their co-investment with New Enterprise Associates in the US$40 million Series A Convertible Preferred Stock financing of Alimera Sciences. The closing of the financing is subject to customary closing conditions.
The O'Melveny deal team was led by partners Paul Scrivano and Brian Covotta, counsel Jeff Cislini, and associate Noah Kornblith.